SCHEMBL6780300

SCHEMBL6780300

COc1ccc(N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc2SC(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTB4R2 Q9NPC1 2/20 0.46
▸ LMNA P02545 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ TP53 P04637 1/20 0.43
▸ LPAR1 Q92633 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PDK1 Q15118 4/20 0.38
▸ PTGES O14684 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP12 P39900 1/20 0.38
▸ MMP1 P03956 1/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ FFAR4 Q5NUL3 1/20 0.38
▸ RNF4 P78317 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6780992 0.89 TSHR (0.45) LTB4R2LMNALPAR1TSHRMEN1
SCHEMBL6780285 0.89 KDM4E (0.41) LTB4R2LMNAALDH1A1LPAR1GAA
SCHEMBL6784549 0.89 LTB4R2 (0.48) LTB4R2LMNAALDH1A1TP53LPAR1
SCHEMBL6779695 0.82 LMNA (0.49) LTB4R2LMNAALDH1A1TP53LPAR1
SCHEMBL6778364 0.81 PTGES (0.56) LTB4R2LMNAALDH1A1TP53LPAR1
SCHEMBL6774057 0.80 LMNA (0.46) LTB4R2LMNAALDH1A1TP53LPAR1
SCHEMBL6778305 0.80 LTB4R2 (0.52) LTB4R2LMNAALDH1A1TP53LPAR1
SCHEMBL6781046 0.79 MEN1 (0.49) LTB4R2LMNAALDH1A1TP53GAA
SCHEMBL6780398 0.79 LMNA (0.51) LTB4R2LMNAALDH1A1TP53LPAR1
SCHEMBL6774704 0.78 TSHR (0.47) LTB4R2LMNAALDH1A1LPAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT LTB4R2 1613/4885LMNA 4203/4885ALDH1A1 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback